Search
for
Sort by
Research 451–480 of 1000+
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- High‐frequency ultrasonography of the scalp: A comparison between androgenetic alopecia and healthy volunteers
- Alleviation of Androgenetic Alopecia with Aqueous Paeonia lactiflora and Poria cocos Extract Intake through Suppressing the Steroid Hormone and Inflammatory Pathway
- Update From Dermatology Nurses’ Association Convention 2025
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Exploring the Mechanisms and Molecular Targets of Taohong Siwu Decoction for the Treatment of Androgenetic Alopecia Based on Network Analysis and Molecular Docking
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Prevalence of Androgenetic Alopecia among Saudi Population
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Trichotillomania in long COVID successfully treated with escitalopram: A case report
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study
- The Roles of EDA2R in Ageing and Disease
- Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study
- The safety and efficacy of finasteride for transgender men with androgenetic alopecia: a case series
- Clinical and demographic characteristics of frontal fibrosing alopecia in a dermatology referral center in Bogota, Colombia: a descriptive cross-sectional study
- The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID
- Effects of Exposure Time to Sun on Hair Fall During Lockdown in Covid Pandemic
- Androgenetic alopecia: may growth factor mimetic oligopeptides supplement minoxidil and finasteride therapy?
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Beyond Hair Loss: Exploring the Evolution of Androgenetic Alopecia Research based on text mining and Bibliometrics
- Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Prevalence and Predictors of Premature Graying of Hair Before the Age of 30: A Cross‐Sectional Study in Saudi Arabia
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024